top of page

Our Mission

Is to significantly improve survival rates and enhance the quality of life for cancer patients worldwide. We focus on developing therapies to ensure that essential pain management does not compromise the effectiveness of cancer treatments.

Our Team

glycyx woman

Justin Chickles

Chief Executive Officer

glycyx woman

Lorin Johnson, PhD

Chief Scientific Officer

glycyx woman

David Taggart

Chief Business Officer

glycyx woman

Bridget Martell

Chief Medical Officer

glycyx woman

Jonathan Moss, MD, PhD

Medical Advisor

Our Advisors

Glycyx is supported by an outstanding network of collaborators from leading cancer centers and biopharmaceutical companies from around the world

glycyx history

Our Journey

Our Policies

Glycyx is committed to transparency and objectivity in research, and our Financial Conflict of Interest Policy ensures compliance with NIH regulations to safeguard the integrity of our federally funded studies.

©2025 by Glycyx Therapeutics

bottom of page